Vanflyta to treat myeloid leukemia
Name: Vanflyta Indications: To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria. Active Ingredient: Quizartinib Company: Daiichi Sankyo, Inc Approval Date:…
Rezlidhia to treat acute myeloid leukemia
Drug Name: Rezlidhia Active Ingredient: olutasidenib Indications: To treat adults with relapsed or refractory acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation Approval Date: 12/1/2022 Company: Forma Therapeutics,…